Armistice Capital, Llc Tenax Therapeutics, Inc. (TENX) insider trading activity

Armistice Capital, LLC is Director of TENAX THERAPEUTICS, INC.. Currently has a direct ownership of 2.02 Million shares of TENX, which is worth approximately $11.3 Million. The most recent transaction as insider was on Sep 08, 2020, when has been sold 8,543 shares (Common Stock) at a price of $1.46 per share, resulting in proceeds of $12,473. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.02M

0% 3M change

0% 12M change

Total Value Held $11.3 Million

ARMISTICE CAPITAL, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 08 2020	BUY Open market or private purchase	$12,473 $1.46 p/Share	8,543 Added 0.42%	2,019,995 Common Stock
Sep 04 2020	BUY Open market or private purchase	$33,074 $1.41 p/Share	23,457 Added 1.15%	2,011,452 Common Stock
Sep 03 2020	BUY Open market or private purchase	$50,040 $1.39 p/Share	36,000 Added 1.78%	1,987,995 Common Stock
Sep 02 2020	BUY Open market or private purchase	$29,400 $1.47 p/Share	20,000 Added 1.01%	1,951,995 Common Stock
Sep 01 2020	BUY Open market or private purchase	$43,800 $1.46 p/Share	30,000 Added 1.53%	1,931,995 Common Stock
Aug 31 2020	BUY Open market or private purchase	$29,000 $1.45 p/Share	20,000 Added 1.04%	1,901,995 Common Stock
Aug 27 2020	BUY Open market or private purchase	$18,000 $1.5 p/Share	12,000 Added 0.63%	1,881,995 Common Stock
Aug 26 2020	BUY Open market or private purchase	$18,000 $1.5 p/Share	12,000 Added 0.64%	1,869,995 Common Stock
Aug 25 2020	BUY Open market or private purchase	$26,333 $1.53 p/Share	17,211 Added 0.92%	1,857,995 Common Stock
Aug 24 2020	BUY Open market or private purchase	$8,367 $1.47 p/Share	5,692 Added 0.31%	1,840,784 Common Stock
Aug 21 2020	BUY Open market or private purchase	$167,388 $1.44 p/Share	116,242 Added 5.96%	1,835,092 Common Stock
Aug 20 2020	BUY Open market or private purchase	$190,442 $1.53 p/Share	124,472 Added 6.75%	1,718,850 Common Stock
Aug 19 2020	BUY Open market or private purchase	$102,612 $1.45 p/Share	70,767 Added 4.25%	1,594,378 Common Stock

Also insider at

AVTX

Avalo Therapeutics, Inc. Healthcare

> 10% Shareholder

BBI

Brickell Biotech, Inc. Healthcare

> 10% Shareholder

ALIM

ALIMERA SCIENCES INC Healthcare

> 10% Shareholder

KPRX

KIORA PHARMACEUTICALS INC Healthcare

> 10% Shareholder

SAVA

CASSAVA SCIENCES INC Healthcare

> 10% Shareholder

DFRG

Del Frisco's Restaurant Group, Inc.

> 10% Shareholder

VLRX

Valeritas Holdings Inc.

> 10% Shareholder

BPTH

BIO-PATH HOLDINGS INC Healthcare

> 10% Shareholder

AYTU

AYTU BIOPHARMA, INC Healthcare

Director

ACHV

ACHIEVE LIFE SCIENCES, INC. Healthcare

> 10% Shareholder

AMAG

AMAG PHARMACEUTICALS, INC.

> 10% Shareholder

RSLS

ReShape Weightloss Inc.

> 10% Shareholder

INNV

INNOVUS PHARMACEUTICALS, INC.

> 10% Shareholder

ONTX

Onconova Therapeutics, Inc. Healthcare

> 10% Shareholder

VXRT

Vaxart, Inc. Healthcare

Director

TTPH

TETRAPHASE PHARMACEUTICALS INC

Director

CYTH

Cyclo Therapeutics, Inc. Healthcare

> 10% Shareholder

RSLS

ReShape Lifesciences Inc. Healthcare

> 10% Shareholder

ACL